Back to Agenda
FOCUS ON MEDICINES EFFICACY, SAFETY AND USAGE IN EDUCATION AND TRAINING
Session Chair(s)
Hans H Linden, MS
Executive Director
EUFEPS, Sweden
People need medicines and they want them to be safe. On medication, we call them patients. IMI was established to enable faster and more efficient development of safe and better medicines for patients. The research consortia include small- and medium-sized enterprises, universities and other research organisations, hospitals, patient organisations, public authorities and large pharmaceutical companies. Contracted deliverables, progress and plans will be presented.
Speaker(s)
Preparing a New Generation of Scientists to Foster Public-Private Partnerships
Michel Goldman, MD, PhD
Institute For Interdisciplinary Innovation In Healthcare (I3H), Belgium
Professor, Immunology and Pharmacotherapy, ULB; Founder
Safety Concerns Are All Over in Medicines Research and Development – Does the new education and training address real life situations in industry and elsewhere?
Dietrich Dan
University of Konstanz, Germany
Why Pharmacovigilance and Pharmacoepidemiology Education and Training in a Medicines Usage Perspective?
Ralph Schimmer, MD, PhD, MBA
Roche Diagnostics Corporation, Switzerland
Chief Medical Officer and Global Head Medical and Scientific Affairs RPD
Have an account?